clindamycin phosphate NDC 0338-9545

NDC codes

FDA NDC Directory

Product NDC (as listed)0338-9545Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00338-9545Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0338-9545-24	00338954524	24 BAG in 1 CARTON (0338-9545-24) / 50 mL in 1 BAG (0338-9545-50)Marketed from Apr 20, 2017

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): clindamycin phosphate
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 300 mg/50mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Baxter Healthcare Company
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 208083
Marketing start: Apr 20, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 0338-9545_b0a47c5e-911b-4b12-a0d1-a4425f173eecSPL ID b0a47c5e-911b-4b12-a0d1-a4425f173eecSPL set ID 44fa506b-90ac-42de-831b-5f3f1a500fc0RxCUI 309335, 309336, 309339UNII EH6D7113I8
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400338954524 followed by a unit qualifier and the quantity

Package 00338-9545-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under NDA 208083

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 208083
Product	Strength	Form · route	Labeler	Product NDC
clindamycin phosphate	Clindamycin phosphate 600 mg/50mL	Injection, SolutionIntravenous	Baxter Healthcare Company	0338-9549
clindamycin phosphate	Clindamycin phosphate 900 mg/50mL	Injection, SolutionIntravenous	Baxter Healthcare Company	0338-9553